Researchers from Perelman School of Medicine at the University of Pennsylvania report the first biomarker results reported from the Parkinson's Progression Markers Initiative (PPMI). It shows that a comprehensive test of protein biomarkers in spinal fluid have prognostic and diagnostic value in early stages of Parkinson's disease. The study is reported in iJAMA Neurology/i. Compared to healthy adults, the study found that people with early Parkinson's ...You have just read an article categorized health
titled Comprehensive Biomarker Test Has Prognostic and Diagnostic Value in Early Stages of Parkinson's Disease.
Written by:
editor - Tuesday, August 27, 2013
There are currently no comments for "Comprehensive Biomarker Test Has Prognostic and Diagnostic Value in Early Stages of Parkinson's Disease"
Post a Comment